Skip to content
10-Q

Quarterly Report

Panbela Therapeutics, Inc.

0001437749-24-035315

← back to feed
Filed
Nov 14, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 11, 2024 4.85M sh
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$12.49M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$22.17M
Long Term Debt Q3 2024 · Sep 30, 2024 $3.19M
Long Term Debt Q3 2024 · Dec 31, 2023 $4.19M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $142K
Cash And Equivalents Q3 2024 · Dec 31, 2023 $2.58M
Stockholders Equity Q3 2024 · Sep 30, 2024 −$18.17M
Stockholders Equity Q3 2024 · Jun 30, 2024 −$10.57M
Stockholders Equity Q3 2024 · Mar 31, 2024 −$3.19M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$4.71M
Stockholders Equity Q3 2024 · Sep 30, 2023 −$2.48M
Stockholders Equity restated Q3 2024 · Jun 30, 2023 $4.8M
Stockholders Equity restated Q3 2024 · Mar 31, 2023 $2.54M
Stockholders Equity Q3 2024 · Dec 31, 2022 −$8.05M
Current Liabilities Q3 2024 · Sep 30, 2024 $20.14M
Current Liabilities Q3 2024 · Dec 31, 2023 $12.32M
Total Liabilities Q3 2024 · Sep 30, 2024 $23.34M
Total Liabilities Q3 2024 · Dec 31, 2023 $16.51M
Current Assets Q3 2024 · Sep 30, 2024 $5.17M
Current Assets Q3 2024 · Dec 31, 2023 $3.06M
Total Assets Q3 2024 · Sep 30, 2024 $5.17M
Total Assets Q3 2024 · Dec 31, 2023 $11.8M
Eps Basic Q3 2024 · Sep 30, 2024 −$1.48
Eps Basic Q3 2024 · Sep 30, 2024 −$5.00
Eps Basic restated Q3 2024 · Sep 30, 2023 −$53.74
Eps Basic restated Q3 2024 · Sep 30, 2023 −$287.01
Sga Expense Q3 2024 · Sep 30, 2024 $1.11M
Sga Expense Q3 2024 · Sep 30, 2024 $3.42M
Sga Expense Q3 2024 · Sep 30, 2023 $1.11M
Sga Expense Q3 2024 · Sep 30, 2023 $4.1M
Rd Expense Q3 2024 · Sep 30, 2024 $6.05M
Rd Expense Q3 2024 · Sep 30, 2024 $18.57M
Rd Expense Q3 2024 · Sep 30, 2023 $6.74M
Rd Expense Q3 2024 · Sep 30, 2023 $14.5M
Net Income Q3 2024 · Sep 30, 2024 −$7.17M
Net Income Q3 2024 · Sep 30, 2024 −$21.44M
Net Income Q3 2024 · Jun 30, 2024 −$7.15M
Net Income Q3 2024 · Mar 31, 2024 −$7.12M
Net Income Q3 2024 · Sep 30, 2023 −$7.83M
Net Income Q3 2024 · Sep 30, 2023 −$18.79M
Net Income restated Q3 2024 · Jun 30, 2023 −$5.85M
Net Income restated Q3 2024 · Mar 31, 2023 −$5.11M
Operating Income Q3 2024 · Sep 30, 2024 −$7.17M
Operating Income Q3 2024 · Sep 30, 2024 −$21.99M
Operating Income Q3 2024 · Sep 30, 2023 −$7.85M
Operating Income Q3 2024 · Sep 30, 2023 −$18.6M